Altimmune (ALT) Cash from Restructuring (2015 - 2017)
Altimmune's Cash from Restructuring came in at -$67,307 for Q3 2016, compared with $10,152 a year earlier.
Powered by 
Analysis
Altimmune (ALT) Cash from Restructuring (2015 - 2017) Analysis & Trends
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Eli Lilly | 1,348.13 Bn | 1,321.74 Bn | 20.46 Bn |
| 2 | Johnson & Johnson | 675.90 Bn | 595.76 Bn | 17.30 Bn |
| 3 | AbbVie | 519.45 Bn | 487.50 Bn | 13.12 Bn |
| 4 | Merck | 364.95 Bn | 327.95 Bn | 13.19 Bn |
| 5 | Novartis Ag | 311.58 Bn | 285.16 Bn | - |
| 6 | Astrazeneca | 289.34 Bn | 262.94 Bn | 13.26 Bn |
| 7 | Amgen | 251.64 Bn | 203.30 Bn | 7.58 Bn |
| 8 | Gilead Sciences | 212.05 Bn | 187.07 Bn | 6.73 Bn |
| 9 | Pfizer | 167.35 Bn | 115.00 Bn | 12.56 Bn |
| 10 | Altimmune | 377.28 Mn | -764.94 Mn | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Mar 31, 2017 | -66,633.00 |
| Dec 31, 2016 | -66,633.00 |
| Sep 30, 2016 | -67,307.00 |
| Jun 30, 2016 | -66,727.00 |
| Mar 31, 2016 | -196,716.00 |
| Dec 31, 2015 | -319,008.00 |
| Sep 30, 2015 | 10,152.00 |
| Jun 30, 2015 | -1.10 Mn |
| Mar 31, 2015 | 1.94 Mn |
API Access
Altimmune Cash from Restructuring API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=cash-from-restructuring&ticker=ALT&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "cash-from-restructuring", "ticker": "ALT", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=cash-from-restructuring&ticker=ALT&period=max&api_key=YOUR_API_KEY");
const data = await res.json();